» Articles » PMID: 35506718

Cutaneous T-cell Lymphoma: Diagnosing Subtypes and the Challenges

Overview
Date 2022 May 4
PMID 35506718
Authors
Affiliations
Soon will be listed here.
Abstract

Cutaneous T-cell lymphoma is a rare type of extranodal non-Hodgkin's lymphoma that primarily affects the skin. The uncertain pathogenesis and variable clinical presentation make the diagnosis and management of cutaneous T-cell lymphoma a challenge. Cutaneous T-cell lymphoma is a chronic, relapsing illness with treatment aimed at symptomatic relief and improving patient related quality of life. Early-stage cutaneous T-cell lymphoma typically follows an indolent course, often being mistaken for benign dermatological conditions which can lead to a diagnostic delay. Advanced stage cutaneous T-cell lymphoma has a poor prognosis with significant morbidity. Accurate diagnosis and early involvement of a specialist team is paramount to ensure correct management and improved patient outcomes. Promising advances are being made to develop novel agents which could improve prognosis and quality of life. This article provides an overview of the two main subtypes of cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome. Clinical presentation, histopathological correlation and diagnostic challenges are reviewed alongside example case studies.

Citing Articles

T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas.

Willscher E, Schultheiss C, Paschold L, Lea Schumann F, Schmidt-Barbo P, Thiele B Haematologica. 2024; 110(2):457-469.

PMID: 39219501 PMC: 11788643. DOI: 10.3324/haematol.2024.285395.


Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species.

Zhu M, Tang W, Tang X, Zhu Z, Jiang Y, Sarwar A J Immunother Cancer. 2024; 12(7).

PMID: 39004437 PMC: 11253763. DOI: 10.1136/jitc-2024-009099.


The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma.

Seretis K, Sfaelos K, Boptsi E, Gaitanis G, Bassukas I Cancers (Basel). 2024; 16(5).

PMID: 38473401 PMC: 10931327. DOI: 10.3390/cancers16051044.


Primary Cutaneous Anaplastic Large Cell Lymphoma-A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features.

Ortiz-Hidalgo C, Pina-Oviedo S Cancers (Basel). 2023; 15(16).

PMID: 37627126 PMC: 10452173. DOI: 10.3390/cancers15164098.